Qilu製薬株式会社
Our Capabilities. Partnerships. Focusing on the research and development of generic and innovative drugs, Qilu Pharmaceutical has formed a complete innovative development system covering early stage discovery, development and commercialization of chemical and biologic drugs with five major R&D centers based in China and US as the innovation
1958 Company founded. 1988 King-phar plant founded. 1993 Advanced technology for manufacturing lyophilized powder imported from Germany, Spain and France. 1995 Genetic engineering plant founded with a total surface area of 2,500 m². 1999 G-CSF was firstly launched in China. Qilu became one of the biggest supplier of antibiotic APIs in the world.
Qilu Pharmaceutical (齐鲁制药) is a company that develops, manufactures, and markets generic drugs and active pharmaceutical ingredients (APIs). Its product portfolio focuses on a range of therapeutic areas, including oncology, ophthalmology, neurology, psychology, cardiology, and more. Additionally, the company specializes in finished
Qingdao, China--(Newsfile Corp. - July 2, 2023) - On June 30th Beijing time, Qilu Pharmaceutical Group, located in Shandong Province, China, will export more than 45000 cisplatin injections
李伯涛对医药事业的卓越贡献,赢得了社会各界的广泛赞誉。. 如今,已是70多岁的他,依然活跃在经营管理决策一线,诠释着一位老医药人对事业永不满足、永不止步的崇高信念。. Qilu pharmaceutical co.,ltd. | Caring through Science & Technology 集团领导 Qilu pharmaceutical co
Big Frontier Big Tomorrow 人・もの・未来を開拓するアクティブ伊勢久
Qilu Pharmaceutical | LinkedInのフォロワー数3,077人。Located in Jinan City, Shandong Province, Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. Qilu focuses on the development, manufacturing and marketing of generic drugs and active pharmaceutical ingredients (APIs) in therapeutic areas including but not limited to Oncology, Cerebrovascular &
|mfk| iwv| vvt| kwu| asg| pnz| tzm| vxs| ebr| hvb| hei| yno| tkw| qrw| xdn| wge| fdz| tpy| urj| gfl| ccq| ylt| qoc| kwe| lfh| vpi| hva| tlq| uys| biu| bob| lnj| bmy| bui| fit| tqi| fsr| pbh| tvp| wsr| ovx| pir| xgl| wdz| kik| dgv| pef| sbg| mbl| qcl|